Real-World, Observational Study Assessing The Proportion Of Leukapheresed Patients with Relapsed and Refractory Multiple Myeloma That Receive Infusion of Idecabtagene Vicleucel (CA089-1097)

ENCePP Code of conduct

No information provided.

Data sources

No information provided.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Yes
• Check completeness:
  Yes
• Check stability:
  Yes
• Check logical consistency:
  Yes

Data characterisation

• Data characterisation conducted:
  Not applicable

Procedures

No information provided.